Metabolic Diseases World Summit 2005. Partnering and deal-making. 29 June-1 July 2005, San Francisco, CA, USA.
Clark
Alan G
AG
Stirling Medical Innovations Ltd, Stirling University Innovation Park, Stirling, FK9 4NF, UK. alanclark@stirlingmedical.com
D001709:Biotechnology; D004345:Drug Industry; D006801:Humans; D008659:Metabolic Diseases / Q000188:drug therapy*; D044105:Receptor, Melanocortin, Type 4 / Q000819:agonists; D014700:Verapamil / Q000627:therapeutic use
D044105:Receptor, Melanocortin, Type 4; C046978:phenoptin; D014700:Verapamil